Investigation of killer cell immunoglobulin-like receptor gene diversity III. KIR2DL3.
The allelic variation of one of the chromosome 19 KIR genes, KIR2DL3, has been investigated using a polymerase chain reaction sequence-specific oligonucleotide probe-based methodology. The procedure has been applied to a healthy Northern Irish control group in order to establish phenotype and genotype frequencies in this Caucasian population. In addition, cell line DNA and Centre d'Etude du Humaine (CEPH) families, both from the 13th International Histocompatibility Workshop have been investigated, establishing control data for this gene.
Keaney
L
L
Northern Ireland Regional Histocompatibility and Immunogenetics Laboratory, City Hospital, Belfast, Northern Ireland.
Williams
F
F
Meenagh
A
A
Sleator
C
C
Middleton
D
D
D000483:Alleles; D001483:Base Sequence; D002460:Cell Line; D002888:Chromosomes, Human, Pair 19 / Q000235:genetics; D014644:Genetic Variation; D006801:Humans; D007694:Killer Cells, Natural / Q000276:immunology; D008969:Molecular Sequence Data; D009660:Northern Ireland; D011971:Receptors, Immunologic / Q000235:genetics* / Q000276:immunology; D054340:Receptors, KIR; D054344:Receptors, KIR2DL3
C515078:KIR2DL3 protein, human; D011971:Receptors, Immunologic; D054340:Receptors, KIR; D054344:Receptors, KIR2DL3